Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 818-823

  Sullivan, Jennifer C ^a   Pollock, Jennifer S ^a   Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelin; ET receptor; Gender; Reactive oxygen species; Salt sensitive hypertension

Indexed keywords

ENDOTHELIN B RECEPTOR; TEMPOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL MODEL; ARTERIAL PRESSURE; CONFERENCE PAPER; FEMALE; HYPERTENSION; MALE; NONHUMAN; RAT; SALT INTAKE; URINARY EXCRETION;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CYCLIC N-OXIDES; DIET; FEMALE; HYPERTENSION; MALE; RATS; RATS, INBRED WKY; RECEPTOR, ENDOTHELIN B; SEX FACTORS; SODIUM CHLORIDE; SPIN LABELS; SUPEROXIDES;

EID: 33744944774     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415, 1994.
2. Pollock DM. Renal endothelin in hypertension. Curr Opin Nephrol Hypertens 9:157-164, 2000.
3. Schiffrin EL. Endothelin and endothelin antagonists in hypertension. J Hypertens 16:1891-1895, 1998.
4. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105:925-933, 2000.
5. B receptor-deficient rats. J Cardiovasc Pharmacol 44:S7-S10, 2004.
6. B receptor-deficient rats: effect of a high salt diet. Hypertension 41:657-662, 2003.
7. Pollock DM, Pollock JS. Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 281:F144-150, 2001.
8. B receptor blockade in rats on a high-salt diet. Hypertension 44:770-775, 2004.
9. A-NADPH oxidase pathway in low-renin hypertension. Circulation 107:1053-1058, 2003.
10. A receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42:811-817, 2003.
11. Loomis ED, Sullivan JC, Osmond DA, Pollock DM, Pollock JS. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther 315:1058-1064, 2005.
12. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, Granger JP. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension 42:806-810, 2003.
13. Gariepy CE, Williams SC, Richardson JA, Hammer RE, Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J Clin Invest 102:1092-1101, 1998.
14. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37:781-786, 2001.
15. 2alpha. Hypertension 33:424-428, 1999.
16. Pollock DM, Rekito A. Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers. Am J Physiol 275(pt 2):R1719-R1723, 1998.
17. Elmarakby AA, Loomis ED, Pollock JS, Pollock DM. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45:283-287, 2005.
18. Wedgwood S, Dettman RW, Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281:L1058-L1067, 2001.
19. A receptors. Am J Physiol Heart Circ Physiol 283:H1555-H1561, 2002.